Metabolic Dysfunction-associated Steatotic Liver Disease: Update and Impact of New Nomenclature on the American Association for the Study of Liver Diseases Practice Guidance on Nonalcoholic Fatty Liver Disease

379 views
October 10, 2024

References:

Rinella ME et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology (2023) 77: 1797-1835.

Rinella ME et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (2023) 78: 1966-1986

Kanwal F et al. Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (2024) 79: 1212-1219.

Comments 1
Login to view comments. Click here to Login